Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Recipharm, a Swedish drug services firm, will pay $59 million to acquire Sanofi’s inhalation drug business in Holmes Chapel, England. It will get a 125,000-m2 facility that specializes in metered dose inhalers and nasal sprays with development areas for dry-powder inhalation technology; the site will supplement Recipharm’s Morrisville, N.C., inhalation facility. Sanofi has signed a long-term supply agreement with Recipharm. The Holmes Chapel business, with annual revenues of about $67 million, currently manufactures Vectra Group’s Flutiform asthma inhaler.
This article has been sent to the following recipient: